Previous close | 91.34 |
Open | 91.44 |
Bid | 94.82 x 100 |
Ask | 95.03 x 200 |
Day's range | 90.85 - 96.40 |
52-week range | 43.89 - 101.00 |
Volume | |
Avg. volume | 813,908 |
Market cap | 5.959B |
Beta (5Y monthly) | 0.65 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Apellis Pharmaceuticals (APLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Blueprint Medicines (BPMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Blueprint Medicines Corporation ( NASDAQ:BPMC ) is possibly approaching a major achievement in its business, so we...